Dr. Thompson was co-director of the center’s melanoma clinic and has led the Fred Hutch Phase 1 Clinical Trials program since 2008, according to a Dec. 19 news release from the center.
He was also a professor in the center’s clinical research division and in the division of hematology and oncology at Seattle-based University of Washington School of Medicine.
After joining Fred Hutch in 1985, Dr. Thompson was among a group of investigators who focused on testing new immunotherapy treatments, laying the groundwork for treatments seen today, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
